Lipid-lowering medications and risk of malignant melanoma: a Mendelian randomization study

BackgroundThe relationship between blood lipids, lipid-modifying medications, and cancer risk has been under investigation for some time. Recent studies suggest that lipid-lowering medications might influence melanoma outcomes, though findings remain controversial. Our study aims to clarify the pote...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	BoWen Yang, HanYu Wang, WenYuan Song, JiuHuan Feng, ShuFang Hou
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-06-01
Subjects:	lipid-lowering medications malignant melanoma cancer Mendelian randomization causal association GWAS
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1408972/full